COMPANION MEETINGS

Hans Popper Hepatopathology Society



  Sunday, March 18, 2012 — 8:30 a.m. — Convention Centre Ballroom C 
  • Liver Disease Update, 2012
  Moderator: David E. Kleiner, Laboratory of Pathology and National Cancer Institute, Bethesda, MD




Click the button above to add this event to your Itinerary Planner...




8:30 Liver Neoplasms—Biology and Classification - Young Nyun Park, Yonsei University College of Medicine, Seoul, South Korea
9:15 Update on Liver Transplantation Pathology - Romil Saxena, Indiana University, Indianapolis, IN
10:00Break
10:30 Drug—induced Liver Injury—A Clinical Perspective - Robert J. Fontana, University of Michigan Medical Center, Ann Arbor, MI
11:15 The Pathology of Acute Liver Injury and Liver Failure - Jay Lefkowitch, Columbia University, New York, NY
This topic was chosen by the executive committee of the Hans Popper Hepatopathology Society in order to address topics that are both challenging to pathologists as well as undergoing revision and reanalysis. The first half of the symposium will address the topics of hepatic neoplasms and liver transplantation. The discussion of liver neoplasms will focus on updating pathologists on the current WHO classification as well as new diagnostic tools and discoveries in pathogenesis. The second talk will focus on new developments in post-transplantation complications including rejection and autoimmune disease. The second half of the symposium will focus on topics that are both diagnostically challenging and critical for acute patient care. We will hear first from a clinician experienced in drug-induced liver injury who will cover both the critical issues in determining the specific cause of the injury as well as the role of the liver biopsy in this process. Finally we will hear what liver pathology can tell us about the etiology, mechanism and prognosis in acute liver failure as well as what can be learned from evidence of regeneration and repair.

The objective of the symposium is to bring pathologists up-to-date on the new development in these critical areas of hepatic pathology.